PharmaNet appoints George Scott VP
This article was originally published in Scrip
PharmaNet Development Group, an inVentiv Health Company and provider of clinical development services, has appointed Dr George Scott vice-president of bioanalytical services. Previously, Dr Scott served as director of pharmacokinetics and drug metabolism at Amgen where he was responsible for overseeing the immunochemistry and small molecule bioanalytical capabilities.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.